1. Home
  2. BOOM vs RLYB Comparison

BOOM vs RLYB Comparison

Compare BOOM & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DMC Global Inc.

BOOM

DMC Global Inc.

HOLD

Current Price

$5.52

Market Cap

109.5M

Sector

Industrials

ML Signal

HOLD

Logo Rallybio Corporation

RLYB

Rallybio Corporation

HOLD

Current Price

$16.20

Market Cap

89.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOOM
RLYB
Founded
1965
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
109.5M
89.2M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
BOOM
RLYB
Price
$5.52
$16.20
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 106.7K
6.3K
Earning Date
10-27-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 89.02
N/A
EPS
N/A
★ 6.16
Revenue
★ $609,840,000.00
$858,000.00
Revenue This Year
$0.34
N/A
Revenue Next Year
$6.80
N/A
P/E Ratio
★ N/A
$2.66
Revenue Growth
N/A
★ 43.00
52 Week Low
$4.69
$0.56
52 Week High
$9.20
$17.57

Technical Indicators

Market Signals
Indicator
BOOM
RLYB
Relative Strength Index (RSI) 43.80 45.26
Support Level $5.50 $15.68
Resistance Level $5.73 $16.50
Average True Range (ATR) 0.26 0.28
MACD 0.02 -0.06
Stochastic Oscillator 42.21 31.13

Price Performance

Historical Comparison
BOOM
RLYB

About BOOM DMC Global Inc.

DMC Global Inc operates a diversified family of technical product and process businesses serving the energy, industrial and infrastructure markets. Its business is organized into three segments: Arcadia, DynaEnergetics, and NobelClad. Arcadia Products supplies architectural building products, including exterior and interior framing systems, windows, urtain walls, storefronts etc to the commercial construction market. NobelClad is involved in the production of explosion-welded clad metal plates for use in the construction of corrosion-resistant industrial processing equipment and specialized transition joints. DynaEnergetics driver, designs manufactures and distributes products utilized by the oil and gas industry principally for the perforation of oil and gas wells.

About RLYB Rallybio Corporation

Rallybio Corp is a clinical-stage biotechnology company comprised of experienced biopharma industry leaders with extensive research, development, and rare disease expertise with a mission to develop and commercialize life-transforming therapies for patients with severe and rare diseases. The company's program, RLYB116, is a differentiated complement component 5 (C5) inhibitor with the potential to treat diseases of complement dysregulation. The Company manages its operations as a single segment for the purposes of allocating resources, assessing performance, and making operating decisions. Rallybio's pipeline also includes RLYB332, a preclinical long-acting matriptase-2 antibody for the treatment of diseases of iron overload.

Share on Social Networks: